Oncology Institute Stock (NASDAQ:TOI)
Previous Close
$4.10
52W Range
$0.13 - $4.50
50D Avg
$3.10
200D Avg
$1.61
Market Cap
$337.32M
Avg Vol (3M)
$2.13M
Beta
0.11
Div Yield
-
TOI Company Profile
The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services. It serves adult and senior cancer patients. The company operates 67 clinic locations. The Oncology Institute, Inc. was founded in 2007 and is based in Cerritos, California.
TOI Performance
Revenue Breakdown
Revenue Breakdown by Product/Service
| Product/Service | Dec 24 | Dec 23 | Dec 22 |
|---|---|---|---|
| Fee For Service | $136.20M | $143.13M | $105.44M |
| Health Care, Patient Service | $204.88M | $213.50M | $166.78M |
| Capitated Revenue | $68.69M | $70.37M | $61.34M |
| Dispensary Revenue | $179.92M | $103.83M | $79.34M |
| Clinical Research Trials And Other Revenue | $8.61M | $6.90M | $6.36M |
Fiscal year ends in Dec 24 | Currency in USD